Trials / Unknown
UnknownNCT05337332
Results of Suprachoroidal Steroids Injections in Two Chorioretinal Diseases
Suprachoroidal Triamcinolone Acetonide Injection in Two Chorioretinal Diseases: One Year Results
- Status
- Unknown
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Benha University · Academic / Other
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Suprachoroidal injection is a safe way for intraocular drug delivery. It was used to treat various retinal conditions.
Detailed description
Suprachoroidal triamcinolone acetonide injection is used to treat various retinal diseases, higher concentration of the injected material is found when the suprachoroidal space is used as an intraocular delivery pathway when compared to the conventional intravitreal pathway.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Triamcinolone Acetonide | Suprachoroidal injection of triamcinolone acetonide |
Timeline
- Start date
- 2022-04-14
- Primary completion
- 2023-05-30
- Completion
- 2023-06-01
- First posted
- 2022-04-20
- Last updated
- 2022-04-20
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05337332. Inclusion in this directory is not an endorsement.